| abstract |
The present invention relates to methods for treating, delaying, slowing the progression and / or preventing disorders, including administering to a subject in need a therapeutically effective amount of a combination therapeutic agent comprising, consisting of or consisting essentially of: (a) canfliflozin and more ACE inhibitors, or one or more ARB, or one or more PPAR gamma agonists; and to methods for treating, delaying, slowing the progression and / or preventing fatty dystrophies of the liver (for example, NASH or NAFLD), including the administration to a subject in need of a therapeutically effective amount of canagliflozin. |